Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
Hani Abdalla, Ebrahim Ebrahim
Abstract
Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remission, following administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. We also briefly reviewed published cases with similar presentations after receiving the SARS-CoV-2 vaccine.
Topics & Concepts
MedicineAlopecia areataAlopecia universalisDermatologyCoronavirus disease 2019 (COVID-19)Hair lossSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusImmunologyVirologyPathologyDiseaseOutbreakInfectious disease (medical specialty)Hair Growth and DisordersAutoimmune Bullous Skin DiseasesDermatologic Treatments and Research